The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index; none of the 48 sources its claims cite is checked for support yet.
Structural Evolution and Dynamics of the p53 Proteins
Open accessAbstract
The family of the p53 tumor suppressive transcription factors includes p73 and p63 in addition to p53 itself. Given the high degree of amino-acid-sequence homology and structural organization shared by the p53 family members, they display some common features (i.e., induction of cell death, cell-cycle arrest, senescence, and metabolic regulation in response to cellular stress) as well as several distinct properties. Here, we describe the structural evolution of the family members with recent advances on the molecular dynamic studies of p53 itself. A crucial role of the carboxy-terminal domain in regulating the properties of the DNA-binding domain (DBD) supports an induced-fit mechanism, in which the binding of p53 on individual promoters is preferentially regulated by the K(OFF) over K(ON).
Overview
CoChat Summary
TL;DR
This review describes the structural organization and evolution of the p53 family and uses molecular dynamics to argue that the intrinsically disordered carboxy-terminal domain regulates DNA-binding domain function through an induced-fit mechanism. It proposes that promoter selectivity depends more on \(K_{\text{OFF}}\) than \(K_{\text{ON}}\) and traces p53-family functions from germ-cell quality control to stem-cell maintenance and tumor suppression.
Key findings
- The p53 family includes p53, p63, and p73, which share domain organization and high amino-acid-sequence homology, especially in the DNA-binding domain (DBD); p63 and p73 are evolutionarily older. In human cancers, 90% of oncogenic p53 mutations lie in the DBD, and p53 binds DNA as a homotetramer with up to 100-fold higher affinity than the single monomer.
- Molecular dynamics of the p53 tetramer-DNA complex shows long-range communication between the carboxy-terminal/oligomerization regions and the DBD, with nonsymmetrical dynamics of loop L1 across the four monomers. The carboxy-terminal domain can induce conformational changes in the DBD, supporting an induced-fit model in which promoter binding selectivity is preferentially regulated by \(K_{\text{OFF}}\) rather than \(K_{\text{ON}}\).
- In the evolutionary model, the ancestral p53-family function was germ-cell quality control. TAp63α is stored as an inactive dimer; DNA-damage phosphorylation via ATM, c-Abl, and Chk2 activates an open tetramer with 20-fold higher DNA-binding affinity, inducing PUMA and NOXA and oocyte death. p73 contributes to blastocyst development and spermatogenesis, while p53 regulates implantation through LIF.
- Full-length p53 MD indicates that the oligomerization domain is fully structured only in the tetrameric form, whereas DBD secondary structure is already formed in the isolated monomer. For mutant R175H, maintaining native Zn binding increases DBD flexibility, while an alternative Zn-binding site reduces carboxy-terminal flexibility.
Methods
- Design: narrative review integrating published structural biology—NMR, electron microscopy, small-angle X-ray scattering, FRET, and crystallography—with molecular dynamics simulations of p53.
- Data/sample: human p53 (393 residues; TAD, PRR, DBD, OD, CTD), p63/p73 isoforms, and cancer-related mutant R175H; MD systems included full-length p53 monomer and p53 tetramer bound to DNA.
- Main analysis: comparison of secondary-structure content over simulation time, per-residue root-mean-square fluctuation over 200 nsec, essential dynamics/eigenvectors, and dynamic cross-correlation maps to infer interdomain motions and induced-fit behavior.
Limitations
- The paper has no dedicated limitations section. It states that intrinsically disordered regions hamper crystallization and that most structural studies have addressed only single domains or fractions; it also states that a full Cryo-EM structure of the p53-DNA complex would provide a more solid base for realistic MD analysis.
- Evident from the text: this is a review synthesizing prior work and the authors’ MD simulations rather than a new experimental study. One MD model lacked carboxy-terminal lysines (Lys370, 372, 373, 381, 382, and 386), which may affect electrostatic conclusions.
- Evident from the text: the induced-fit/\(K_{\text{OFF}}\) conclusion is based on MD and cited in vitro/in vivo studies, and the authors note that additional transcriptional-complex partners cannot be disregarded.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 4 Not valid · 34 Not checked · 34 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Binding of the HMGB1 A box (blue) with TAD2 influences the p53 (orange) binding with DNA (not shown).”
§ Structural Evolution and Dynamics of the p53 Proteins > CONCLUDING REMARKS
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The average fluctuation observed by molecular dynamics (MD) (200 nsec) shows different degrees of movement depending on the distinct region of p53 in the wild-type form (black line); point color code as in Fig. 1 (amino terminal, green; DBD [DNA-binding domain], red; carboxyl terminal, blue).”
§ Structural Evolution and Dynamics of the p53 Proteins > CONCLUDING REMARKS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mutant p53 isoforms shows a drastic change in flexibility.”
§ Structural Evolution and Dynamics of the p53 Proteins > CONCLUDING REMARKS
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lysine residues are important also for DNA binding.”
§ Structural Evolution and Dynamics of the p53 Proteins > CONCLUDING REMARKS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Long-range communications between p53 transactivation domains (TADs) and DNA-binding domains (DBDs) have been observed in the full-length molecular dynamic (MD) simulation with an anticorrelation motion (highlighted by the arrow) that structurally connect TADs with the Lys120 region in DBD.”
§ Structural Evolution and Dynamics of the p53 Proteins > CONCLUDING REMARKS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 72 claims and to verify the 38 references still open.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 5
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The p53 protein is a transcription factor comprising five domains: a transactivation domain divided into two regions responsible for activating the transcription of multiple genes, a proline‐rich domain (PRD) involved in the regulation of apoptosis, a 200‐amino‐acid‐residue DNA‐binding domain (DBD), a tetramerization domain (TET) that enables the oligomerization of the p53 monomers, and a negative”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [25]
In the citing paper
“It contains an N-terminal transactivation domain (TAD, residues 1–61), a proline-rich domain (PRD, residues 64–92), a DNA-binding domain (DBD, residues 96–292) linked to a tetramerization domain (TET, residues 324–356), and a C-terminal regulatory domain (CTD, residues 364–393)260,261 (Fig. 4b).”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [260]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Structural Evolution and Dynamics of the p53 Proteins > STRUCTURE AND MOLECULAR DYNAMICS OF p53
“the first in which the binding site for the ion is conserved ( purple line in Fig. 4) and the other in which it is coordinated to H175 (orange line in Fig. 4).”
§ Structural Evolution and Dynamics of the p53 Proteins > CONCLUDING REMARKS
“The p53 R175H mutant that maintains the native Zn binding (yellow line) has increased the flexibility of DBD, indicating a potential abnormal binding to the selected promoter.The p53 R175H mutant that has an alternative Zn-binding site ( purple line) has reduced flexibility of the carboxyl terminus, suggesting abnormal transactivation properties.”
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Self-citationCrystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 2×
“The DBD core domain adopts an immunoglobulin-like b sandwich architecture that provides a scaffold for a DNA-binding surface, consisting of a loop–sheet–helix motif and two loops stabilized by a zinc ion (Cho et al. 1994; Joerger and Fersht 2010).”
BackgroundApplication of a Theory of Enzyme Specificity to Protein Synthesis
Koshland, D. E. (1958) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.44.2.98 · Cited by 2,396
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,225
p63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X.-J., Vogel, H., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,988
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Structural basis for the binding of proline-rich peptides to SH3 domains
Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., & Schrelber, S. L. (1994) · Cell · doi:10.1016/0092-8674(94)90367-0 · Cited by 1,001
Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 990
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Regulation of p53 activity through lysine methylation
Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K., Tempst, P., Prives, C., Gamblin, S. J., et al. (2004) · Nature · doi:10.1038/nature03117 · Cited by 816
p53 isoforms can regulate p53 transcriptional activity
Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Di Fiore, P. P., & Pelicci, P. G. (2009) · Cell · doi:10.1016/j.cell.2009.06.048 · Cited by 696
Structural Biology of the Tumor Suppressor p53
Joerger, A. C., & Fersht, A. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.060806.091238 · Cited by 693
Crystal Structure of the Tetramerization Domain of the p53 Tumor Suppressor at 1.7 Angstroms
Jeffrey, P. D., Gorina, S., & Pavletich, N. P. (1995) · Science · doi:10.1126/science.7878469 · Cited by 549
p63 protects the female germ line during meiotic arrest
Suh, E.-K., Yang, A., Kettenbach, A., Bamberger, C., Michaelis, A. H., Zhu, Z., Elvin, J. A., Bronson, R. T., Crum, C. P., & McKeon, F. (2006) · Nature · doi:10.1038/nature05337 · Cited by 549
Murray-Zmijewski, F., Lane, D. P., & Bourdon, J.-C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401914 · Cited by 523
Posttranslational Modification of p53: Cooperative Integrators of Function
Meek, D. W., & Anderson, C. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000950 · Cited by 483
Drosophila p53 Binds a Damage Response Element at the reaper Locus
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. M. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 473
Identification of a novel p53 functional domain that is necessary for efficient growth suppression
Walker, K. K., & Levine, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15335 · Cited by 471
Self-citationCaenorhabditis elegans p53: Role in Apoptosis, Meiosis, and Stress Resistance
Derry, W. B., Putzke, A. P., & Rothman, J. H. (2001) · Science · doi:10.1126/science.1065486 · Cited by 464
p53 regulates maternal reproduction through LIF
Hu, W., Feng, Z., Teresky, A. K., & Levine, A. J. (2007) · Nature · doi:10.1038/nature05993 · Cited by 445
Self-citationTAp73 knockout shows genomic instability with infertility and tumor suppressor functions
Tomasini, R., Tsuchihara, K., Wilhelm, M., Fujitani, M., Rufini, A., Cheung, C. C., Khan, F., Itie-Youten, A., Wakeham, A., Tsao, M.-S., et al. (2008) · Genes & Development · doi:10.1101/gad.1695308 · Cited by 429
Self-citationDrosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53
Ollmann, M., Young, L. M., Di Como, C. J., Karim, F., Belvin, M., Robertson, S., Whittaker, K., Demsky, M., Fisher, W. W., Buchman, A., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80626-1 · Cited by 412
Structural Basis of DNA Recognition by p53 Tetramers
Kitayner, M., Rozenberg, H., Kessler, N., Rabinovich, D., Shaulov, L., Haran, T. E., & Shakked, Z. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.015 · Cited by 408
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Boeckler, F. M., Joerger, A. C., Jaggi, G., Rutherford, T. J., Veprintsev, D. B., & Fersht, A. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805326105 · Cited by 387
The Tumor Suppressor p53: From Structures to Drug Discovery
Joerger, A. C., & Fersht, A. R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000919 · Cited by 357
Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death
Gonfloni, S., Di Tella, L., Caldarola, S., Cannata, S. M., Klinger, F. G., Di Bartolomeo, C., Mattei, M., Candi, E., De Felici, M., Melino, G., et al. (2009) · Nature Medicine · doi:10.1038/nm.2033 · Cited by 346
Self-citationp63 and p73, the ancestors of p53
Dotsch, V., Bernassola, F., Coutandin, D., Candi, E., & Melino, G. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004887 · Cited by 326
Self-citationStructure of the negative regulatory domain of p53 bound to S100B(betabeta).
Weber, D. J., Rust, R. R., & Baldisseri, D. M. (2000) · Nature Structural Biology · doi:10.1038/76797 · Cited by 314
Venot, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4668 · Cited by 292
Reversal of Female Infertility by Chk2 Ablation Reveals the Oocyte DNA Damage Checkpoint Pathway
Bolcun-Filas, E., Rinaldi, V. D., White, M. E., & Schimenti, J. C. (2014) · Science · doi:10.1126/science.1247671 · Cited by 277
p53 Contains Large Unstructured Regions in its Native State
Bell, S., Klein, C., Müller, L., Hansen, S., & Buchner, J. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00848-3 · Cited by 275
Kerr, J. B., Hutt, K. J., Michalak, E. M., Cook, M., Vandenberg, C. J., Liew, S. H., Bouillet, P., Mills, A., Scott, C. L., Findlay, J. K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.017 · Cited by 263
The p53 family: guardians of maternal reproduction
Levine, A. J., Tomasini, R., McKeon, F. D., Mak, T. W., & Melino, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3086 · Cited by 252
Self-citationSomatic TP53 Mutations in the Era of Genome Sequencing
Hainaut, P., & Pfeifer, G. P. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026179 · Cited by 231
The N-terminal Domain of p53 is Natively Unfolded
Dawson, R., Müller, L., Dehner, A., Klein, C., Kessler, H., & Buchner, J. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.08.008 · Cited by 229
p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53
Melino, G. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.81 · Cited by 224
Self-citationComputational identification of a transiently open L1/S3 pocket for reactivation of mutant p53
Wassman, C. D., Baronio, R., Demir, Ö., Wallentine, B. D., Chen, C.-K., Hall, L. V., Salehi, F., Lin, D.-W., Chung, B. P., Wesley Hatfield, G., et al. (2013) · Nature Communications · doi:10.1038/ncomms2361 · Cited by 223
Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2
Ferreon, J. C., Lee, C. W., Arai, M., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811023106 · Cited by 210
A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism
Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H. G., van Bokhoven, H., McKeon, F., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8601-8611.2002 · Cited by 205
Self-citationRole of Induced Fit in Enzyme Specificity: A Molecular Forward/Reverse Switch
Johnson, K. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800034200 · Cited by 204
Isoform-specific p73 knockout mice reveal a novel role for ΔNp73 in the DNA damage response pathway
Wilhelm, M. T., Rufini, A., Wetzel, M. K., Tsuchihara, K., Inoue, S., Tomasini, R., Itie-Youten, A., Wakeham, A., Arsenian-Henriksson, M., Melino, G., et al. (2010) · Genes & Development · doi:10.1101/gad.1873910 · Cited by 203
Self-citationDi Lello, P., Jenkins, L. M. M., Jones, T. N., Nguyen, B. D., Hara, T., Yamaguchi, H., Dikeakos, J. D., Appella, E., Legault, P., & Omichinski, J. G. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.007 · Cited by 192
p53 Isoforms: Key Regulators of the Cell Fate Decision
Joruiz, S. M., & Bourdon, J.-C. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026039 · Cited by 190
p53 Linear Diffusion along DNA Requires Its C Terminus
McKinney, K., Mattia, M., Gottifredi, V., & Prives, C. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.032 · Cited by 174
The Transactivation Domains of the p53 Protein
Raj, N., & Attardi, L. D. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026047 · Cited by 168
TAp73 depletion accelerates aging through metabolic dysregulationPreprint
Rufini, A., Niklison-Chirou, M. V., Inoue, S., Tomasini, R., Harris, I. S., Marino, A., Federici, M., Dinsdale, D. D., Knight, R. A., Melino, G., et al. (2012) · Genes & Development · doi:10.1101/gad.197640.112 · Cited by 136
Self-citationTAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity
Tomasini, R., Tsuchihara, K., Tsuda, C., Lau, S. K., Wilhelm, M., Rufini, A., Tsao, M., Iovanna, J., Jurisicova, A., Melino, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812096106 · Cited by 132
Self-citationDNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63α from Dimer to Tetramer
Deutsch, G. B., Zielonka, E. M., Coutandin, D., Weber, T. A., Schäfer, B., Hannewald, J., Luh, L. M., Durst, F. G., Ibrahim, M., Hoffmann, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.01.013 · Cited by 131
Self-citationCandau, R., Scolnick, D. M., Darpino, P., Ying, C. Y., Halazonetis, T. D., & Berger, S. L. (1997) · Oncogene · doi:10.1038/sj.onc.1201244 · Cited by 131
Nagaich, A. K., Zhurkin, V. B., Durell, S. R., Jernigan, R. L., Appella, E., & Harrington, R. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1875 · Cited by 127
The impact of p53 and p73 on aneuploidy and cancer
Tomasini, R., Mak, T. W., & Melino, G. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.03.003 · Cited by 127
Self-citationChang, J., Kim, D., Lee, S. W., Choi, K. Y., & Sung, Y. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.25014 · Cited by 126
Chen, Y., Bates, D. L., Dey, R., Chen, P., Machado, A. C. D., Laird‐Offringa, I. A., Rohs, R., & Chen, L. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.012 · Cited by 126
Rowell, J. P., Simpson, K. L., Stott, K., Watson, M., & Thomas, J. O. (2012) · Structure · doi:10.1016/j.str.2012.09.004 · Cited by 125
Laptenko, O., Shiff, I., Freed-Pastor, W., Zupnick, A., Mattia, M., Freulich, E., Shamir, I., Kadouri, N., Kahan, T., Manfredi, J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.015 · Cited by 119
Structure of the p53 Core Domain Dimer Bound to DNA
Ho, W. C., Fitzgerald, M. X., & Marmorstein, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603634200 · Cited by 118
Beyer, U., Moll-Rocek, J., Moll, U. M., & Dobbelstein, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016201108 · Cited by 117
An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity
Petty, T. J., Emamzadah, S., Costantino, L., Petkova, I., Stavridi, E. S., Saven, J. G., Vauthey, E., & Halazonetis, T. D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.127 · Cited by 117
Basse, N., Kaar, J. L., Settanni, G., Joerger, A. C., Rutherford, T. J., & Fersht, A. R. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.12.011 · Cited by 113
The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity
Okorokov, A. L., Sherman, M. B., Plisson, C., Grinkevich, V., Sigmundsson, K., Selivanova, G., Milner, J., & Orlova, E. V. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601382 · Cited by 110
Huang, F., Rajagopalan, S., Settanni, G., Marsh, R. J., Armoogum, D. A., Nicolaou, N., Bain, A. J., Lerner, E., Haas, E., Ying, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909644106 · Cited by 108
Structural evolution of C‐terminal domains in the p53 family
Ou, H. D., Löhr, F., Vogel, V., Mäntele, W., & Dötsch, V. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601764 · Cited by 108
Self-citationRegulation of DNA Binding of p53 by its C-terminal Domain
Weinberg, R. L., Freund, S. M. V., Veprintsev, D. B., Bycroft, M., & Fersht, A. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.042 · Cited by 97
TAp73 Acts via the bHLH Hey2 to Promote Long-Term Maintenance of Neural Precursors
Fujitani, M., Cancino, G. I., Dugani, S. B., Weaver, I. C. G., Gauthier-Fisher, A., Paquin, A., Mak, T. W., Wojtowicz, M. J., Miller, F. D., & Kaplan, D. R. (2010) · Current Biology · doi:10.1016/j.cub.2010.10.029 · Cited by 89
Crystal structure of a p53 core tetramer bound to DNA
Malecka, K. A., Ho, W. C., & Marmorstein, R. (2008) · Oncogene · doi:10.1038/onc.2008.400 · Cited by 87
TAp73 is required for spermatogenesis and the maintenance of male fertility
Inoue, S., Tomasini, R., Rufini, A., Elia, A. J., Agostini, M., Amelio, I., Cescon, D., Dinsdale, D., Zhou, L., Harris, I. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323416111 · Cited by 86
Self-citationGordo, S., Martos, V., Santos, E., Menéndez, M., Bó, C., Giralt, E., & de Mendoza, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805658105 · Cited by 86
Hamard, P.-J., Barthelery, N. J., Hogstad, B., Mungamuri, S. K., Tonnessen-Murray, C. A., Carvajal, L. A., Senturk, E., Gillespie, V., Aaronson, S. A., Mérad, M., et al. (2013) · Genes & Development · doi:10.1101/gad.224386.113 · Cited by 79
Greiss, S., Schumacher, B., Grandien, K., Rothblatt, J. A., & Gartner, A. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-334 · Cited by 71
Structure of Human SMYD2 Protein Reveals the Basis of p53 Tumor Suppressor Methylation
Wang, L., Li, L., Zhang, H., Luo, X., Dai, J., Zhou, S., Gu, J., Zhu, J., Atadja, P. W., Lu, C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262410 · Cited by 70
Molecular Dynamics Simulations of p53 DNA-Binding Domain
Lü, Q., Tan, Y.-H., & Luo, R. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp0742261 · Cited by 69
Melero, R., Rajagopalan, S., Lázaro, M., Joerger, A. C., Brandt, T., Veprintsev, D. B., Lasso, G., Gil, D., Scheres, S. H. W., Carazo, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015520107 · Cited by 64
Early diversification and complex evolutionary history of the p53 tumor suppressor gene family
Nedelcu, A. M., & Tan, C. A. (2007) · Development Genes and Evolution · doi:10.1007/s00427-007-0185-9 · Cited by 63
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53
Joerger, A. C., Bauer, M. R., Wilcken, R., Baud, M. G. J., Harbrecht, H., Exner, T. E., Boeckler, F. M., Spencer, J., & Fersht, A. R. (2015) · Structure · doi:10.1016/j.str.2015.10.016 · Cited by 63
TAp73 is essential for germ cell adhesion and maturation in testis
Holembowski, L., Kramer, D., Riedel, D., Sordella, R., Nemajerová, A., Dobbelstein, M., & Moll, U. M. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201306066 · Cited by 59
p53-Dependent p21 mRNA Elongation Is Impaired when DNA Replication Is Stalled
Mattia, M., Gottifredi, V., McKinney, K. M., & Prives, C. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01520-06 · Cited by 55
D'Abramo, M., Bešker, N., Desideri, A., Levine, A. J., Melino, G., & Chillemi, G. (2016) · Oncogene · doi:10.1038/onc.2015.388 · Cited by 51
Self-citationDifferences in the transactivation domains of p53 family members: a computational study
Mavinahalli, J., Madhumalar, A., Beuerman, R. W., Lane, D. P., & Verma, C. S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-s1-s5 · Cited by 50
Reversal of the DNA-Binding-Induced Loop L1 Conformational Switch in an Engineered Human p53 Protein
Emamzadah, S., Tropia, L., Vincenti, I., Falquet, B., & Halazonetis, T. D. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.12.020 · Cited by 49
Dynamic sensitivity analysis of biological systems
Wu, W. H., Wang, F. S., & Chang, M. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-s12-s17 · Cited by 46
Analysis of the oligomeric state and transactivation potential of TAp73α
Luh, L. M., Kehrloesser, S., Deutsch, G. B., Gebel, J., Coutandin, D., Schäfer, B., Agostini, M., Melino, G., & Dötsch, V (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.23 · Cited by 44
Self-citationKim, D.-A., & Suh, E.-K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01223-13 · Cited by 44
The Role of the p53 Protein in Stem-Cell Biology and Epigenetic Regulation
Levine, A. J., Puzio-Kuter, A. M., Chan, C. S., & Hainaut, P. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026153 · Cited by 43
Self-citationDemir, Ö., Baronio, R., Salehi, F., Wassman, C. D., Hall, L., Hatfield, G. W., Chamberlin, R., Kaiser, P., Lathrop, R. H., & Amaro, R. E. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002238 · Cited by 39
Tracing the Evolution of the p53 Tetramerization Domain
Joerger, A. C., Wilcken, R., & Andreeva, A. (2014) · Structure · doi:10.1016/j.str.2014.07.010 · Cited by 35
Molecular dynamics of the full-length p53 monomer
Chillemi, G., Davidovich, P., D’Abramo, M., Mametnabiev, T., Garabadzhiu, A. V., Desideri, A., & Melino, G. (2013) · Cell Cycle · doi:10.4161/cc.26162 · Cited by 31
Self-citationModelling the interaction between the p53 DNA‐binding domain and the p28 peptide fragment of Azurin
Santini, S., Bizzarri, A. R., & Cannistraro, S. (2011) · Journal of Molecular Recognition · doi:10.1002/jmr.1153 · Cited by 28
Stability of the core domain of p53: insights from computer simulations
Madhumalar, A., Smith, D. J., & Verma, C. S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-s1-s17 · Cited by 20
Allen, W. J., Capelluto, D. G. S., Finkielstein, C. V., & Bevan, D. R. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1011445 · Cited by 17
Noda, T. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.08.029 · Cited by 15
p53 R175H hydrophobic patch and H ‐bond reorganization observed by MD simulation
Thayer, K. M., & Quinn, T. R. (2015) · Biopolymers · doi:10.1002/bip.22766 · Cited by 11
Heering, J., Jonker, H. R. A., Löhr, F., Schwalbe, H., & Dötsch, V. (2015) · Protein Science · doi:10.1002/pro.2830 · Cited by 8
Self-citationTAp73 acts via the bHLH Hey2 to promote long-term maintenance of neural precursors
Fujitani, M., Miller, F. D., & Kaplan, D. R. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.07.277 · Cited by 6
Relative Stability of Wild-Type and Mutant p53 Core Domain: A Molecular Dynamic Study
Rohani, L., Morton, D. J., Wang, X., & Chaudhary, J. (2015) · Journal of Computational Biology · doi:10.1089/cmb.2015.0163 · Cited by 3
Research works printed but not linked: 1
- 2015, Structural investigations of the p53/p73 homologs from the tunicate species Ciona intestinalis reveal the sequence requirements for the formation of a tetramerization domain, Protein Sci, 25, 410
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Towards the overcoming of anticancer drug resistance mediated by p53 mutations
Cao, X., Hou, J., An, Q., Assaraf, Y. G., & Wang, X. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100671 · Cited by 172
p53 Isoforms and Their Implications in Cancer
Vieler, M., & Sanyal, S. (2018) · Cancers · doi:10.3390/cancers10090288 · Cited by 153
Evolution of cellular stress response mechanisms
Kültz, D. (2020) · Journal of Experimental Zoology Part A Ecological and Integrative Physiology · doi:10.1002/jez.2347 · Cited by 134
Emerging Roles of p53 Family Members in Glucose Metabolism
Itahana, Y., & Itahana, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030776 · Cited by 123
Metadata
- Authors
- Chillemi, G., Kehrloesser, S., Bernassola, F., Desideri, A., Dötsch, V., Levine, A. J., & Melino, G.
- Affiliations
- Cineca (IT)
- Goethe University Frankfurt (DE)
- University of Rome Tor Vergata (IT)
- Institute for Advanced Study (US)
- University of Leicester (GB)
- ORCID
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-04-18
- Volume
- 7
- Issue
- 4
- Pages
- a028308
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC5378015
- OpenAlex
- W2339239589
- Semantic Scholar
- 939889fb53c563be7ad87b332a0f35db24bb7c87
- Cited by
- 65
- References
- 96
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- UnitusOpen (Tuscia University) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro (AIRC 2014 IG15653, AIRC 5xmille MCO9979, AIRC 5xmille, 5 x mille, IG15653)
- Fondazione Roma
- Medical Research Council
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, p73, p63, p53 family, structural evolution, molecular dynamics, C-terminal domain, DNA-binding domain, induced fit, promoter binding, cell death, cell cycle arrest, senescence, cellular stress response
- MeSH terms
- Tumor Protein p73, Binding Sites, Humans, Promoter Regions, Genetic, Transcription Factors, Trans-Activators, Tumor Suppressor Protein p53, Tumor Suppressor Proteins, Molecular Dynamics Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.